Atlas, Reasons I think, Your Making Big Mistake When I

New Post Public Reply Private Reply Replies (3) Message Board
truthaboutcompanies Atlas1 #24968
Atlas, Reasons I think, Your Making Big Mistake

When I say Your (I mean, everyone who has repeatedly said that he needs to meet this deadline, this started WEEKS ago... wouldn't you agree?) just to be clear!

1. So many people on this Board Complain that they don't share enough, and/or don't have enough PR's!

Look at your guys Behavior when some information is released...
When a company says 15-30 Days, Everyone knows that it means 30 days before they are late, and even then, some possible small delays could occur! (15 is best case scenario and very Unlikely)!
People have been Saying again FOR WEEKS now, that people should send emails to IR and basically harass the Company and CEO about Movies(That the DEADLINE has NOT EVEN COME YET)!

You have also set up a No win Situation. Because they have received so many emails and people all over the boards, are harassing them about the movies, before the deadline, if he loads all 100 Movies by the deadline... nothing positive is going to happen, but negative things have already happened for the last 3 weeks! It has given the people attacking the company ammunition, and quite frankly, NTEK is being Criticized, and they have not even came to the deadline yet!

2. Do you really think that this behavior, has made NTEK want to release more PR's and/or information to the shareholder's when they are so critical and do not even allow the company the time it was supposed to be given?

Now if the company announces anything, they know, that if the finish it by the announced deadline, that is not good enough! This is in no way helpful to shareholder's, the business, or anyone!

3. Some of you seem not to have noticed the fact that SOMETHING WAY BIGGER may be going on, because your so obsessed with this deadline! You seem to have glanced over the fact that the Company has Moved up a Huge amount in the last few days, and it Looks like there are very big things to come!

So here is the very important Question Atlas? What does the CEO or NTEK GAIN if they meet the Deadline?
The answer seems to be Nothing, according to pretty much everyone. Not only do they not gain anything, they have already taken so much heat, for no reason, so really it was already a losing venture, to release that information!

We may have to face the fact, that many of us were Right! PR's are used by Basher's to Attack NTEK...

And many of our longs are so impatient, they do not even allow the proper amount of time for the company to accomplish, what they released!

It Just seems like, looking at this from the Company's perspective, they should not release information until after, (which then upsets some longs, who think they should be told everything in advance)!

So honestly speaking Atlas, is anything I have written incorrect? And this is with a 50% share increase, otherwise the talk and harassment of NEK and the CEO would have been HORRIBLE the last 3 Days!
UI am curious as to your opinion after reading this.

Thanks Atlas, nothing personal, I am just trying to explain to you why I think you guys are scaring away, the information you want,

truthaboutcompanies

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CAE Boosts Fiscal 2027 Outlook; Transformation On Track

Updated Category News Views 116

Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...

Continue Reading
Ingram Micro Joins S&P SmallCap 600 Amid M&A Moves

Updated Category News Views 87

Market Shufflin’ as Ingram Micro Steps In The constant ebb and flow of the stock market got right interesting with Ingram Micro Holding Corp. (NYSE: INGM) slated to crawl into the S&P SmallCap 600. This dance change-up is all thanks to Viatris Inc. (NASD: VTRS) looking to wrap up its acquisition of Pacira BioSciences (NASD: PCRX). With this deal sealing the fate of...

Continue Reading
'Luz de las Naciones' Event: A Cultural Milestone

Updated Category News Views 67

A Vibrant Showcase of Culture and Faith Grab your seatbelt, because when you hear about a cultural event lighting up the scene, especially one backed by The Church of Jesus Christ of Latter-day Saints, it means something's brewing. We're diving headfirst into 'Luz de las Naciones,' a celebration that's keeping its promise to highlight Latin America's zest and vibrant...

Continue Reading
Elron Ventures Advances Dual-Use Tech Investment Plans

Updated Category News Views 19

A Strategic Dance through Conferences Elron Ventures is gearing up for an action-packed November slate, aiming to flaunt its prowess in investment across burgeoning tech fields like Defense Tech, Deep Tech, Cybersecurity, and AI. Now, any seasoned investor knows these are the buzzy sectors that could just be the workhorses pulling the future market cart. But what makes...

Continue Reading
GFL's Big Share Conversion: Impact and Implications

Updated Category News Views 0

Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...

Continue Reading
China's Double 11 Fest Rings in $264B in 2026

Updated Category News Views 8

Shifting Gears at the 2026 Double 11 Festival You blinked, and another record was shattered. China's "Double 11" Shopping Festival, with its rhythmic frenzy and relentless countdowns, clocked a staggering RMB 1,776.4 billion this year—roughly US$264.4 billion. This ain't no ordinary sale, it's a financial juggernaut, folks. As these platforms duke it out for every yuan,...

Continue Reading
DarioHealth Eyes Growth with Rising Revenue and Reduced Costs

Updated Category News Views 0

Quarterly Earnings Reflect Strategic Forward Movement This quarter, DarioHealth (NASDAQ: DRIO) decided to crank up the volume on its long-haul strategy. They've managed a respectable 6% revenue increase over last year, clocking in at $5.3 million for the third quarter of 2026. It's a slight nudge up from the previous quarter too, where they sat at $5.2 million. Not...

Continue Reading
Can BWIN, CCC, PCRX Deals Really Serve Shareholders?

Updated Category News Views 28

Shareholder Stakes: Caught in Controversy Well, here we go again. These days, it seems like shareholder lawsuits are cropping up as regularly as sunrise. We've got Halper Sadeh LLC on a warpath, targeting potential legal missteps in the megadeals involving Baldwin Group (NASDAQ:BWIN), CCC Intelligent Solutions Holdings (NASDAQ:CCC), and Pacira BioSciences (NASDAQ:PCRX)....

Continue Reading
Eli Radiopharma Clinches Big Series A, Eyes Milestones

Updated Category News Views 103

Making Waves in Radiopharmaceuticals Some days, it's not just about the numbers—it’s about the shift in an entire field. Eli Radiopharma just closed a grand RMB 400 million Series A financing, paving a path that could redefine radiopharmaceuticals. Kinfolk over at Huagai Capital led the charge, teaming up with Bayland Capital and a throng of other backers. They’re...

Continue Reading
BSR REIT's Q3 2026 Financials: Strategic Progress Made

Updated Category News Views 57

BSR REIT Hits Strategic Milestones in Q3 Here's a bit of exciting news hitting us from BSR Real Estate Investment Trust. They've dropped their financial results for the third quarter of 2026. Packed with some solid gains, this quarter wasn't just about the numbers—it was about the moves they've been making underneath it all. So, let's break down what they're up to, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Indy Autonomous Challenge Unveils Multicar Racing at CES 2025

Updated Category News Views 312

Indy Autonomous Challenge Returns at CES 2025 The Indy Autonomous Challenge (IAC), a global leader in high-speed autonomy, is poised for an exciting return to CES 2025 with groundbreaking developments, including the introduction of multicar racing and advancements in physical AI. This event, taking place in January 2025 at the Las Vegas Motor Speedway, promises a...

Continue Reading
Veris Residential, Inc. Sets Webcast for Q2 2025 Financials

Updated Category News Views 200

Veris Residential, Inc. Plans Webcast for Q2 Financial Results Veris Residential, Inc. provides an exciting update for shareholders and potential investors. The company has announced it will host a webcast for its second quarter 2025 financial results. This marks an important opportunity for stakeholders to gain insights into the company's performance and future...

Continue Reading
Bank Expert Shares Tips for Effortless Checking Setup

Updated Category News Views 129

Streamlining Your Checking Account Setup Tossing out the right prep can turn opening a checking account from a headache to a breeze. Banking luminary Abigail White spills the beans in a HelloNation piece, shedding light on how getting your ducks in a row with documents and features puts you in the driver’s seat of financial well-being. The Basics: Identification and...

Continue Reading
Serabi Gold Announces Robust Mid-Year Financial Performance

Updated Category News Views 207

Serabi Gold Reports Strong Interim Results for 2024 Serabi Gold plc (LSE: SRB, TSX: SBI) has unveiled its unaudited financial results for the first half of 2024, demonstrating impressive growth and strategic investments during this period. Strong Financial Performance Clive Line, the Chief Financial Officer of Serabi Gold, emphasized the company's financial successes in...

Continue Reading
Innovative Strategies in Drug Development: A New Era with BullFrog AI

Updated Category News Views 190

Transforming Drug Development with Innovative AI Solutions From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence. In a market valued over $200 billion and saturated with black-box AI, BullFrog AI's bfLEAP™ stands out by offering biologically grounded analytics that steer strategic...

Continue Reading